TAMPA, Fla., Feb. 18, 2016 -- PPJ Healthcare Enterprises Inc. (OTC Pink:PPJE) announced today that it has executed 7l contracts, including Valley Herbal in Los Angeles area, to perform medical marijuana testing. The Company expects to execute a total of 100 contracts over the next 90 days and estimates that it could generate about $20,000 in revenue per dispensary per year.
“The signing of these contracts puts us in the position of being able to hit the ground running when the doors open,” said Chandana Basu, CEO of PPJ Healthcare Enterprises Inc. “The opening of our testing facility coupled with our recently announced pain clinic are significant steps in the Company’s plans to expand our business and work with partners that need key elements that we can offer.”
The Company anticipates the lab could open as early as next 45 to 60 days.
“We are working diligently to grow shareholder value through these continuous partnership opportunities. This strategy will not only allow us to expand at a quicker pace, but allows us to share the expense and risks associated with opening clinics and labs,” Basu said.
Forward-looking Statements
Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Healthcare Enterprises Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project” and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises cautions you that any forward-looking information provided by or on behalf of PPJ Enterprise is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises’ actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond PPJ Enterprise’s control. In addition to those discussed in PPJ Healthcare Enterprises’ press releases, public filings and statements by PPJ Healthcare Enterprises’ management, including, but not limited to, PPJ Healthcare Enterprises’ estimate of sufficiency of its existing capital resources, PPJ Healthcare Enterprises’ ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises’ ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match PPJ Healthcare Enterprises’ capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.
PPJ Healthcare Enterprises, Inc.
401 E. Jackson St., Suite 2340
Tampa, Florida 33602
Telephone: (813) 693-5192
Fax: (866) 622-3215
Websites: https://www.ppjenterprise.com
http://ppjenterprisedotorg.wordpress.com
https://www.automatedbiller.com
https://www.professionalbillingservice.net
https://www.facebook.com/PPJEnterprise
https://www.linkedin.com/pub/chandana-basu/76/6a1/137
https://www.twitter.com/PPJEnterprise


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 



